The estimated Net Worth of Andrew Fenton is at least $7.62 Milion dollars as of 6 December 2019. Andrew Fenton owns over 3,044 units of Zoetis Inc stock worth over $4,668,814 and over the last 8 years Andrew sold ZTS stock worth over $2,950,087.
Andrew has made over 5 trades of the Zoetis Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Andrew exercised 3,044 units of ZTS stock worth $578,330 on 6 December 2019.
The largest trade Andrew's ever made was selling 13,870 units of Zoetis Inc stock on 2 September 2016 worth over $710,838. On average, Andrew trades about 1,271 units every 34 days since 2016. As of 6 December 2019 Andrew still owns at least 24,574 units of Zoetis Inc stock.
You can see the complete history of Andrew Fenton stock trades at the bottom of the page.
Andrew's mailing address filed with the SEC is C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY, NJ, 07054.
Over the last 12 years, insiders at Zoetis Inc have traded over $876,669,659 worth of Zoetis Inc stock and bought 1,602,140 units worth $77,083,975 . The most active insiders traders include Square Capital Management, ..., Frank A Damelio a Michael B Mccallister. On average, Zoetis Inc executives and independent directors trade stock every 14 days with the average trade being worth of $14,414,921. The most recent stock trade was executed by Soria Ester Banque on 31 July 2024, trading 895 units of ZTS stock currently worth $170,041.
Zoetis Inc. is an American drug company, the worlds largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the worlds largest drug maker, but with Pfizers spinoff of its 83% interest in the firm it is now a completely independent company.
Zoetis Inc executives and other stock owners filed with the SEC include: